Latest1 information on COVID-19
©2022 Stanford Medicine
Comparison of Once Daily Versus 8 Hour Dosing of Gentamicin for the Treatment of Intrapartum Chorioamnionitis
Not Recruiting
Trial ID: NCT00185991
Purpose
To compare once daily versus 8 hour dosing of gentamicin for the treatment of
chorioamnionitis.
Official Title
Comparison of Once Daily Versus 8 Hour Dosing of Gentamicin for the Treatment of Intrapartum Chorioamnionitis
Stanford Investigator(s)
Yasser El-Sayed, Professor
Charles B. and Ann L. Johnson Professor in the School of Medicine and Professor, by courtesy, of Pediatrics (Neonatology) and of Surgery
Eligibility
Inclusion Criteria:
- clinical diagnosis of chorioamnionitis
Exclusion Criteria:
- maternal renal disease, intrauterine fetal death, allergy to gentamicin
Intervention(s):
drug: gentamicin
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Yasser El-Sayed
6507233198